Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

TERBINAFINE HYDROCHLORIDE

TERBINAFINE HYDROCHLORIDE

Standard Dose
EQ 250MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TERBINAFINE HYDROCHLORIDE is listed in Drugs@FDA under application 078297 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TERBINAFINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 250MG BASE Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2019-12-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview TERBINAFINE HYDROCHLORIDE is listed in Drugs@FDA under application 078297 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TERBINAFINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 250MG BASE Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2019-12-03 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.